🔬 This Week’s Top Biotech News

Here are the biggest stories shaping the world of biotechnology this week 👇

1. Eisai – Health Canada Grants Authorization for LEQEMBI® (lecanemab) for Early Alzheimer’s Disease
2. Biopharma Embraces Synthetic Biology
3. Sanofi-Aventis Canada – Dupixent® (dupilumab injection) approved for COPD
4. StockWatch: Intellia Shares Sink as Clinical Hold Follows Safety Setback
5. Bird Flu’s Human Risk Spurs Phage Therapy Research
6. This Retina Implant Lets People with Vision Loss Do a Crossword Puzzle
7. Neurenati Therapeutics – EMA Grants Orphan Drug Designation to NEU-001 for Hirschsprung Disease
8. The Astonishing Embryo Models of Jacob Hanna
9. The Latest Company Planning for Gene-Edited Babies
10. Mass Spec Brings Multiomics Into Sharper Focus
11. Why We Don’t Have a Cold Vaccine — Yet
12. Job Titles of the Future: AI Embryologist
    
    

🧬 From Alzheimer’s breakthroughs to gene editing ethics and synthetic biology advances, biotech continues to evolve at lightning speed.

What story caught your attention this week?

#Biotech #Biotechnology #Science #Innovation #Healthcare #Research #LifeSciences